Search

for
Search:

GlossaryGonadotropin-releasing hormone (LHRH)

regulates release of reproductive hormones from the pituitary gland

Gonadotropin-releasing hormone (GnRH) is a key hormone produced in the hypothalamus of the brain. It regulates the release of two other important hormones from the pituitary gland: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). These hormones are crucial for reproductive function, including the development of eggs in ovaries and sperm in testes.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 158 results

research Characteristics of Flutamide Action on Prostatic and Testicular Functions in the Rat

30 citations, June 1988 in “Journal of Steroid Biochemistry”

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

research Incidence of Liver Toxicity Associated with the Use of Flutamide in Prostate Cancer Patients

116 citations, May 1992 in “The American Journal of Medicine”

Flutamide rarely causes liver toxicity in prostate cancer patients.

research New Methods of Endocrine Management of Prostatic Cancer

67 citations, January 1987 in “The Journal of urology/The journal of urology”

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

research Cyproterone Acetate in the Treatment of Sexual Disorders: Pharmacological Basis and Clinical Experience

30 citations, July 2009 in “Experimental and clinical endocrinology & diabetes”

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

research Hormonal Manipulation of Benign Prostatic Hyperplasia

18 citations, November 2012 in “Current opinion in urology”

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

View more "lhrh" in research →

Community Join

1 / 1 results

community Why haven’t we seen anything about this

in Research/Science 18 upvotes 5 years ago

A double blind, placebo-controlled study that looked into the potential effectiveness of topical fluridil for treating male androgenetic alopecia, showing increased anagen to telogen ratios with no reported side effects on libido or sexual performance.